Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2009-010966-47-DE
EUCTR2009-010966-47-DE
Active, not recruiting
Not Applicable

Clinical Effectiveness Of The Newer Antipsychotic Compounds Olanzapine, Quetiapine And Aripiprazole In Comparison With Low Dose Conventional Antipsychotics (Haloperidol And Flupentixol) In Patients With SchizophreniaThe Neuroleptic Strategy Study - NeSSy - NeSSy

niversität Bremen0 sitesOctober 14, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSchizophreniaMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
DrugsHaloperidol 1.5 mg tabletSeroquel Prolong 200 mg RetardtablettenDepixol® Tablets 3 mgZyprexaABILIFY 5 mg Tabletten

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Schizophrenia
Sponsor
niversität Bremen
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 14, 2009
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
niversität Bremen

Eligibility Criteria

Inclusion Criteria

  • •Key inclusion criteria:
  • •Patients with schizophrenia, age 18\-65, necessity to establish new or change antipsychotic treatment due to unsatisfying results or side effects.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 630
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Key exclusion criteria:
  • •Acute suicidal tendency, Einwilligungsvorbehalt (BGB)” or Unterbringung (PsychKG), organic psychosis, history of malignant neuroleptic syndrome, QTc interval \= 0\.5s / history of congenital QTc prolongation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
Clinical effectiveness of the newer antipsychotic compounds olanzapine, quetiapine and aripiprazole in comparison with low dose conventional antipsychotics (haloperidol and flupentixol) in patients with schizophreniaF20Schizophrenia
DRKS00000304niversität BremenKompetenzzentrum für Klinische Studien Bremen, Biometrie149
Completed
Not Applicable
Efficacy of treatment with antipsychotics in patients with psychotic disorder. The value of amino acid profile and neurotrophic proteins.psychosisschizophrenia10039628
NL-OMON31735GGZ Groep Noord en Midden-Limburg100
Completed
Not Applicable
Real-world effectiveness of antipsychotic treatments in acutely hospitalized patients with schizophrenia: multi-center prospective observational study
JPRN-UMIN000045925Juntendo University481
Completed
Not Applicable
The investigation of the antipsychotic effects of adding d-penicillamine to risperidone on schizophrenia.schizophrenia.?????????
IRCT20131007014928N6Mazandaran University of Medical Science.32
Completed
Not Applicable
Comparative effect of second-generation antipsychotic blonanserin and aripiprazole on cognitive impairment in first-episode schizophrenia: An open-label trialschizophrenia
JPRN-UMIN000010827Department of Neuropsychiatry St. Marianna University School of Medicine60